Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition
- Resource Type
- Article
- Source
- In
International Journal of Biochemistry and Cell Biology April 2024 169 - Subject
- Language
- ISSN
- 1357-2725